Group One Trading’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $24.5K | Sell |
142
-3,636
| -96% | -$628K | ﹤0.01% | 1407 |
|
2025
Q1 | $589K | Sell |
3,778
-323
| -8% | -$50.3K | ﹤0.01% | 508 |
|
2024
Q4 | $565K | Buy |
+4,101
| New | +$565K | ﹤0.01% | 617 |
|
2024
Q3 | – | Hold |
0
| – | – | – | 1794 |
|
2024
Q2 | – | Hold |
0
| – | – | – | 1817 |
|
2024
Q1 | – | Sell |
-5,808
| Closed | -$732K | – | 1842 |
|
2023
Q4 | $732K | Buy |
5,808
+2,964
| +104% | +$373K | ﹤0.01% | 457 |
|
2023
Q3 | $266K | Buy |
+2,844
| New | +$266K | ﹤0.01% | 676 |
|
2023
Q2 | – | Hold |
0
| – | – | – | 1862 |
|
2023
Q1 | – | Sell |
-1,235
| Closed | -$151K | – | 1911 |
|
2022
Q4 | $151K | Sell |
1,235
-16,130
| -93% | -$1.97M | ﹤0.01% | 806 |
|
2022
Q3 | $1.79M | Buy |
17,365
+11,321
| +187% | +$1.17M | ﹤0.01% | 270 |
|
2022
Q2 | $562K | Buy |
+6,044
| New | +$562K | ﹤0.01% | 578 |
|
2022
Q1 | – | Hold |
0
| – | – | – | 2078 |
|
2021
Q4 | – | Hold |
0
| – | – | – | 2212 |
|
2021
Q3 | – | Sell |
-11
| Closed | -$1K | – | 2114 |
|
2021
Q2 | $1K | Sell |
11
-220
| -95% | -$20K | ﹤0.01% | 1913 |
|
2021
Q1 | $30K | Sell |
231
-710
| -75% | -$92.2K | ﹤0.01% | 1479 |
|
2020
Q4 | $157K | Buy |
+941
| New | +$157K | ﹤0.01% | 915 |
|
2020
Q3 | – | Hold |
0
| – | – | – | 1571 |
|
2020
Q2 | – | Sell |
-569
| Closed | -$64K | – | 1427 |
|
2020
Q1 | $64K | Sell |
569
-1,219
| -68% | -$137K | ﹤0.01% | 778 |
|
2019
Q4 | $249K | Buy |
1,788
+565
| +46% | +$78.7K | ﹤0.01% | 591 |
|
2019
Q3 | $118K | Sell |
1,223
-4,392
| -78% | -$424K | ﹤0.01% | 702 |
|
2019
Q2 | $647K | Buy |
+5,615
| New | +$647K | 0.01% | 283 |
|
2019
Q1 | – | Sell |
-1,345
| Closed | -$84K | – | 1244 |
|
2018
Q4 | $84K | Buy |
+1,345
| New | +$84K | ﹤0.01% | 784 |
|
2018
Q3 | – | Sell |
-98
| Closed | -$7K | – | 1417 |
|
2018
Q2 | $7K | Buy |
+98
| New | +$7K | ﹤0.01% | 1174 |
|